Can a simple dilator prevent radiation side effects in anal cancer patients?
NCT ID NCT04094454
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for women with anal cancer who need pelvic radiation. It tests whether using a vaginal dilator during each radiation session can reduce the risk of vaginal narrowing (stenosis) after treatment. Half of the 60 participants will use the dilator during radiation, and the other half will not. The goal is to see if this simple device can cut the rate of vaginal narrowing in half, from 50% to 25%.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital of Heidelberg, Radiation Oncology
RECRUITINGHeidelberg, 69120, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an immunotherapy drug boost the power of chemoradiation against anal cancer?
- Can anal cancer treatment spare sexual well-being? a study tracks the toll over two years.
- HIV and cancer: study seeks to uncover hidden risk factors
- What do gay men know about anal cancer screening? a new survey aims to find out
- New drug combo targets HPV-Driven cancers in phase II trial
- Vitamins e and CoQ10 tested as shield against radiation damage